Currently out of the existing stock ratings of Craig Bijou, 60 are a BUY (58.82%), 27 are a HOLD (26.47%), 15 are a SELL (14.71%).

Craig Bijou

Work Performance Price Targets & Ratings Chart

Analyst Craig Bijou, currently employed at BAML, carries an average stock price target met ratio of 72.22% that have a potential upside of 22.88% achieved within 253 days.

Craig Bijou’s has documented 211 price targets and ratings displayed on 29 stocks. The coverage is on Healthcare, Consumer Cyclical sectors.

Most recent stock forecast was given on AXGN, Axogen at 12-Oct-2026.

Wall Street Analyst Craig Bijou

Analyst best performing recommendations are on RMED (RA MEDICAL SYSTEMS).
The best stock recommendation documented was for RMED (RA MEDICAL SYSTEMS) at 8/13/2019. The price target of $2500 was fulfilled within 7 days with a profit of $987.5 (65.29%) receiving and performance score of 93.27.

Average potential price target upside

ISRG Intuitive Surgical OFIX Orthofix Medical AXGN Axogen GMED Globus Medical IART Integra LifeSciences Holdings SIBN Si-Bone VRAY ViewRay NUVA NuVasive RMED RA Medical Systems SYK Stryker WMGI Wright Medical Group N.V ITGR Integer Holdings Corp BLCO Bausch + Lomb Corp PRCT Procept Biorobotics Corp RXST Rxsight COO The Cooper Companies MMSI Merit Medical Systems GEHC GE HealthCare Technologies BWAY Brainsway Ltd CERS Cerus SPNE SeaSpine Holdings Corp TFX Teleflex XGN Exagen ZBH Zimmer Biomet Holdings HAE Haemonetics ECOR Electrocore LLC SGHT Sight Sciences VRA Vera Bradley PACB Pacific Biosciences of California

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 27-Jan-2026

$485

$32.71 (7.23%)

$485

7 days ago
(21-Oct-2026)

0/4 (0%)

$56.88 (13.29%)

Buy Since 16-Oct-2023

$503

$50.71 (11.21%)

$454

7 days ago
(21-Oct-2026)

4/10 (40%)

$74.88 (17.49%)

66

Buy Since 18-Jul-2023

$550

$97.71 (21.60%)

$500

7 days ago
(21-Oct-2026)

10/16 (62.5%)

$121.88 (28.47%)

127

Buy Since 24-May-2017

$486

$33.71 (7.45%)

$487

7 days ago
(21-Oct-2026)

28/34 (82.35%)

$57.88 (13.52%)

155

Buy Since 11-Oct-2024

$475

$22.71 (5.02%)

$450

7 days ago
(21-Oct-2026)

2/5 (40%)

$46.88 (10.95%)

97

Show more analysts

Please expand the browser size to see the chart

Which stock is Craig Bijou most bullish on?

Potential upside of $13.94 has been obtained for AXGN (AXOGEN)

Which stock is Craig Bijou most reserved on?

Potential downside of -$38.51 has been obtained for HAE (HAEMONETICS)

What Year was the first public recommendation made by Craig Bijou?

On 2018
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?